Greg Bell, Andrew Tepperman, and Justin Ho co-authored a chapter in the ninth edition of The Investment Treaty Arbitration Review. The chapter titled “Investment Treaty Disputes in the Life Sciences Industry” addresses the features and incentives of the life sciences industry as they lead to tensions and disputes between governments and companies. The chapter further discusses valuation considerations for practitioners and future issues arising from current developments in the life sciences industry.
An evidence-based framework to determine funding requirements for NCCPs
The report finds that NCCPs rarely specify the funds that need to be committed or the spending that occurs in practice. When evidence of funding impact is...